Goldman Sachs’s Avanos Medical AVNS Stock Holding History

Goldman Sachs’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-50,000	Closed	-$2.86M	–	5555
2018 Q2	$2.86M	Buy	+50,000	New	+$2.64M	﹤0.01%	3362
2017 Q1	–	Sell	-1,380	Closed	-$51K	–	6742
2016 Q4	$51K	Hold	1,380	–	–	﹤0.01%	6381
2016 Q3	$48K	Hold	1,380	–	–	﹤0.01%	6485
2016 Q2	$45K	Sell	1,380 -50,000	-97%	-$1.53M	﹤0.01%	6459
2016 Q1	$1.48M	Sell	51,380 -1,224	-2%	-$32.6K	﹤0.01%	3749
2015 Q4	$1.76M	Buy	52,604 +49,988	+1,911%	+$1.55M	﹤0.01%	3756
2015 Q3	$74K	Sell	2,616 -120	-4%	-$4.19K	﹤0.01%	6636
2015 Q2	$111K	Sell	2,736 -1,380	-34%	-$61.9K	﹤0.01%	6554
2015 Q1	$203K	Sell	4,116 -7,032	-63%	-$326K	﹤0.01%	6007
2014 Q4	$507K	Buy	+11,148	New	+$438K	﹤0.01%	5265

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Goldman Sachs's AVNS Position: Q1 2026 in Review

Goldman Sachs increased its Avanos Medical (AVNS) stake by 6.5% in Q1 2026, buying an estimated $397K and bringing the position to 480,886 shares worth $6.74M. The position accounts for ﹤0.01% of the portfolio, ranked #3413.

Goldman Sachs first reported a position in AVNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $99M in Q3 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

Goldman Sachs held 480,886 shares of Avanos Medical worth $6.74M as of Q1 2026.
Goldman Sachs bought 29,497 Avanos Medical shares in Q1 2026, an estimated $397K.
Avanos Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3413 holding.
Goldman Sachs first reported a position in Avanos Medical in Q4 2014 and has held it in 46 quarters since.
Goldman Sachs's Avanos Medical position peaked at $99M in Q3 2018.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.